P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach
暂无分享,去创建一个
Stephan Kopp | Peter Chiba | Andreas Rizzi | Gerhard F Ecker | Karin Pleban | G. Ecker | P. Chiba | E. Csaszar | A. Rizzi | T. Hrebicek | Thomas Hrebicek | Edina Csaszar | Michael Peer | S. Kopp | Karin Pleban | Michael Peer
[1] K. Linton,et al. Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.
[2] D. Clarke,et al. Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12* , 1997, The Journal of Biological Chemistry.
[3] R. Leduc,et al. METHIONINE PROXIMITY ASSAY, A NOVEL METHOD FOR EXPLORING PEPTIDE LIGAND–RECEPTOR INTERACTION , 2002, Journal of receptor and signal transduction research.
[4] G Ecker,et al. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. , 1999, Biochemical pharmacology.
[5] G Ecker,et al. Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance. , 1995, Journal of medicinal chemistry.
[6] G. Prestwich,et al. Using photolabile ligands in drug discovery and development. , 2000, Trends in biotechnology.
[7] T. Janvilisri,et al. The ATP Binding Cassette Multidrug Transporter LmrA and Lipid Transporter MsbA Have Overlapping Substrate Specificities* , 2003, Journal of Biological Chemistry.
[8] M. Schumacher,et al. Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. , 2003, Research in microbiology.
[9] K J Schaper,et al. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance. , 1996, Journal of medicinal chemistry.
[10] Chava Kimchi-Sarfaty,et al. P-glycoprotein: from genomics to mechanism , 2003, Oncogene.
[11] A. Neyfakh. Mystery of multidrug transporters: the answer can be simple , 2002, Molecular microbiology.
[12] D. Clarke,et al. The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis* , 2000, The Journal of Biological Chemistry.
[13] Gerry McDermott,et al. Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump , 2003, Science.
[14] H. Omote,et al. Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein* , 2003, Journal of Biological Chemistry.
[15] G Ecker,et al. The importance of a nitrogen atom in modulators of multidrug resistance. , 1999, Molecular pharmacology.
[16] H. Nikaido,et al. AcrB Multidrug Efflux Pump of Escherichia coli: Composite Substrate-Binding Cavity of Exceptional Flexibility Generates Its Extremely Wide Substrate Specificity , 2003, Journal of bacteriology.
[17] C. Higgins,et al. Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.
[18] Z. Sauna,et al. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] Stephan Kopp,et al. Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. , 2002, Molecular pharmacology.
[20] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] P. Chiba,et al. Photoaffinity labeling of P-glycoprotein. , 2005, Mini reviews in medicinal chemistry.
[22] G Ecker,et al. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. , 1996, Molecular pharmacology.
[23] D. Gadsby,et al. ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. , 1997, Seminars in cancer biology.
[24] A. Garnier-Suillerot,et al. A Structural Model for the Open Conformation of the mdr1 P-glycoprotein Based on the MsbA Crystal Structure* , 2003, Journal of Biological Chemistry.
[25] D. Clarke,et al. Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular Rulers* , 2001, The Journal of Biological Chemistry.
[26] P. Biggin,et al. Extending the structure of an ABC transporter to atomic resolution: modeling and simulation studies of MsbA. , 2003, Biochemistry.
[27] I. Pastan,et al. Expression of the human multidrug transporter in insect cells by a recombinant baculovirus. , 1990, Biochemistry.
[28] J. Lawson,et al. Structural Model of the Regulatory Domain of Smooth Muscle Heavy Meromyosin* , 2003, The Journal of Biological Chemistry.
[29] D. Clarke,et al. Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.
[30] D. Clarke,et al. Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.
[31] Z. Sauna,et al. Characterization of the Catalytic Cycle of ATP Hydrolysis by Human P-glycoprotein , 2001, The Journal of Biological Chemistry.
[32] Geoffrey Chang,et al. Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. , 2003, Journal of molecular biology.
[33] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[34] G. Ecker,et al. A Three-Dimensional Model for the Substrate Binding Domain of the Multidrug ATP Binding Cassette Transporter LmrA , 2004, Molecular Pharmacology.
[35] Peter R. Baker,et al. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. , 1999, Analytical chemistry.
[36] D. Clarke,et al. Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Clarke,et al. Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein* , 2003, Journal of Biological Chemistry.
[38] K. Linton,et al. An atomic detail model for the human ATP binding cassette transporter P‐glycoprotein derived from disulphide cross‐ linking and homology modeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.